Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
ROA % is calculated as Net Income divided by its average Total Assets over a certain period of time. Touyun Biotech Group's annualizedNet Income for the quarter that ended in Dec. 2025 was HK$31.11 Mil.
Touyun Biotech Group's average Total Assets over the quarter that ended in Dec. 2025 was HK$616.46 Mil. Therefore, Touyun Biotech Group's annualized ROA % for the quarter that ended in Dec. 2025 was 5.05%.
The historical rank and industry rank for Touyun Biotech Group's ROA % or its related term are showing as below:
HKSE:01332'
s ROA % Range Over the Past 10 Years
Min: -100.87 Med: -19.73 Max: 4.58
Current: 4.51
During the past 13 years, Touyun Biotech Group's highest ROA % was 4.58%. The lowest was -100.87%. And the median was -19.73%.
HKSE:01332's ROA % is ranked better than 65.09% of 401
companies
in the Packaging & Containers industry
Industry Median: 2.73
vs HKSE:01332: 4.51
Touyun Biotech Group (HKSE:01332) ROA % Explanation
ROA % measures the rate of return on the total assets (shareholder equity plus liabilities). It measures a firm's efficiency at generating profits from shareholders' equity plus its liabilities. ROA % shows how well a company uses what it has to generate earnings. ROA %s can vary drastically across industries. Therefore, ROA % should not be used to compare companies in different industries. For retailers, a ROA % of higher than 5% is expected. For example, Wal-Mart (WMT) has a ROA % of about 8% as of 2012. For banks, ROA % is close to their interest spread. A banks ROA % is typically well under 2%.
Similar to ROE, ROA % is affected by profit margins and asset turnover. This can be seen from the Du Pont Formula:
Note:
The Net Income data used here is two times the semi-annual (Dec. 2025) net income data. The Revenue data used here is two times the semi-annual (Dec. 2025) revenue data.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
Like ROE, ROA % is calculated with only 12 months data. Fluctuations in the company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. ROA % can be affected by events such as stock buyback or issuance, and by goodwill, a company's tax rate and its interest payment. ROA % may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).
Many analysts argue the higher return the better. Buffett states that really high ROA % may indicate vulnerability in the durability of the competitive advantage.
E.g. Raising $43b to take on KO is impossible, but $1.7b to take on Moody's is. Although Moody's ROA % and underlying economics is far superior to Coca Cola, the durability is far weaker because of lower entry cost.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Packaging & Containers subindustry, Touyun Biotech Group's ROA %, along with its competitors' market caps and ROA % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Touyun Biotech Group ROA % vs Packaging & Containers Industry
For the Packaging & Containers industry and Consumer Cyclical sector, Touyun Biotech Group's ROA % distribution charts can be found below:
* The bar in red indicates where Touyun Biotech Group's ROA % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual ROA %, the net income of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data,
the Net Income data used here is two times the semi-annual (Dec. 2025) net income data.
ROA % is displayed in the 30-year financial page.
Touyun Biotech Group (HKSE:01332) has a ROA % of 5.05% as of Dec. 2025. Return on assets is the ratio of current-period net income to average two-period total assets. View historical data on Touyun Biotech Group and its competitors. According to the industry distribution chart, Touyun Biotech Group ranks #140 out of 401 companies in the Packaging & Containers industry, placing it in the top 34.9%.
Is Touyun Biotech Group's ROA % too high?
Touyun Biotech Group's current ROA % is 5.05%. The Packaging & Containers industry median ROA % is 2.73. Touyun Biotech Group's value of 5.05% is 85% above this industry median. Based on the distribution chart, Touyun Biotech Group ranks #140 out of 401 companies in the Packaging & Containers industry, which is above the industry midpoint. Overall, Touyun Biotech Group has a GF Score™ of 25/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Touyun Biotech Group's ROA % compare to SW and PKG?
According to the Packaging & Containers industry distribution chart, Touyun Biotech Group ranks #140 out of 401 companies for ROA %. This puts Touyun Biotech Group in the upper half of its industry. The industry median ROA % is 2.73. Touyun Biotech Group's value of 5.05% is 85% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROA % for a Packaging & Containers company?
The median ROA % among Packaging & Containers companies is 2.73, based on 401 companies in the industry. Companies in the top quartile (top 25%) have a ROA % significantly above this median, while those in the bottom quartile fall well below. However, ROA % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Touyun Biotech Group's current ROA % of 5.05% is 85% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROA % mean?
A high ROA % can signal that a stock is expensive relative to its fundamentals. Return on assets is the ratio of current-period net income to average two-period total assets. View historical data on Touyun Biotech Group and its competitors. For the Packaging & Containers industry, the median ROA % is 2.73 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Touyun Biotech Group's current ROA % is 5.05%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Touyun Biotech Group stock overvalued right now?
Based on GuruFocus' analysis, Touyun Biotech Group (HKSE:01332) is currently considered Fairly Valued. The stock's GF Value™ is HK$0.16, compared to a current price of HK$0.15 — trading 3.8% below its estimated fair value. The current ROA % is 5.05% and 85% above the Packaging & Containers industry median of 2.73. Touyun Biotech Group's overall GF Score™ is 25/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROA % calculated?
ROA % is calculated from a company's financial statements. For Touyun Biotech Group (HKSE:01332), the current ROA % is 5.05% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Touyun Biotech Group (HKSE:01332) Overvalued in 2026?
Based on GuruFocus' analysis, Touyun Biotech Group stock appears to be undervalued.
The current stock price of HK$0.15 is trading 3.8% below its estimated GF Value™ of HK$0.16.
GuruFocus considers Touyun Biotech Group to be Fairly Valued.
Key valuation signals for HKSE:01332:
ROA %: 5.05%
GF Value™: HK$0.16 vs. price of HK$0.15 (3.8% below fair value)
Industry Position: 85% above the Packaging & Containers median (#140 of 401)
No single metric tells the full story. See the HKSE:01332 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Touyun Biotech Group Ltd is principally engaged in the (i) the manufacture and sale of packaging products; (ii) investments and trading in securities and money lending, and (iii) production and sale of Chlamydomonas reinhardtii, micro-algae and related products. The company generates majority of its revenue from packaging products segment.
25GF Score
Get the complete analysis for HKSE:01332
ROA % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HKSE:01332 has been successfully added to your 
